Lorey K. Smith
Impact in
-
- Cancer-related Molecular Pathways
-
- Hippo pathway signaling and YAP/TAZ
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
-
- Melanoma and MAPK Pathways 5
- Epigenetics and DNA Methylation 3
- Wnt/β-catenin signaling in development and cancer 3
- Fibroblast Growth Factor Research 2
- Protein Degradation and Inhibitors 2
- RNA modifications and cancer 2
- Co-authors
- Grant A. McArthur (8 shared papers)Karen E. Sheppard (7 shared papers)Patrick Orson Humbert (4 shared papers)Aparna Dodla Rao (2 shared papers)Nathan Gödde (2 shared papers)Helen B. Pearson (2 shared papers)Emily J. Lelliott (2 shared papers)Ryan C. Galea (1 shared paper)
- Journals
- Cancers (5 papers)Journal for ImmunoTherapy of Cancer (2 papers)Cancer Cell (1 paper)Experimental Cell Research (1 paper)Clinical and Translational Medicine (1 paper)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Lorey K. Smith
19 papers receiving 473 citations
Peers
Comparison fields: 5 of 67
- Oncology 136
- Cell Biology 75
- Molecular Biology 303
- Cancer Research 57
- Immunology 47
Countries citing papers authored by Lorey K. Smith
This map shows the geographic impact of Lorey K. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorey K. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorey K. Smith more than expected).
Fields of papers citing papers by Lorey K. Smith
This network shows the impact of papers produced by Lorey K. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorey K. Smith. The network helps show where Lorey K. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Lorey K. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 99 | |
| 2 | 2014 | 51 | |
| 3 | 2020 | 37 | |
| 4 | 2022 | 37 | |
| 5 | 2016 | 32 | |
| 6 | 2022 | 25 | |
| 7 | 2021 | 22 | |
| 8 | 2021 | 22 | |
| 9 | 2021 | 22 | |
| 10 | 2014 | 21 | |
| 11 | Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death | 2023 | 21 |
| 12 | 2022 | 21 | |
| 13 | 2013 | 14 | |
| 14 | 2015 | 12 | |
| 15 | 2023 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 5 | |
| 19 | 2025 | 4 |
About Lorey K. Smith
Lorey K. Smith is a scholar working on Oncology, Molecular Biology, Cell Biology, Immunology and Reproductive Medicine, having authored 19 papers that have together received 476 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Epigenetics and DNA Methylation (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), CAR-T cell therapy research (2 papers), Fibroblast Growth Factor Research (2 papers), Protein Degradation and Inhibitors (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (136 citations), Cell Biology (75 citations), Molecular Biology (303 citations), Cancer Research (57 citations) and Immunology (47 citations). Lorey K. Smith has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Grant A. McArthur, Karen E. Sheppard, Patrick Orson Humbert, Aparna Dodla Rao, Nathan Gödde, Helen B. Pearson, Emily J. Lelliott, Ryan C. Galea, Jane E. Visvader and Kara L. Britt. Their work appears in journals such as Cancers, Journal for ImmunoTherapy of Cancer, Cancer Cell, Experimental Cell Research and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.